Start: September 2014
End: June 30, 2019
What Is This Study About?
This study will compare two intervention strategies for reducing emotional and cardiovascular disease risk in Alzheimer's caregivers: Behavioral Activation therapy and Support and Information.
Do I Qualify To Participate in This Study?
- Providing in-home care to a spouse with dementia
Must NOT have:
- Prohibited medications: warfarin (Coumarin), nitrates, niacin, non-selective beta-blockers, methyldopa (Aldomet), labetalol (Normozide)
- Glucocorticoid use in the 2 weeks before enrollment
- Diagnosis of a terminal illness with life expectancy of less than 1 year (caregiver and person with Alzheimer's)
- Enrollment in another intervention study
- Receiving psychotherapy to improve well-being or reduce stress
- Blood pressure of more than 200/120 mm Hg
If I Qualify, Who Do I Contact?
Contact study personnel listed either under the general study contact or the location nearest you.
Brent T. Mausbach, PhD
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Where Is This Study Located?
University of California San Diego
La Jolla, CA 92093
Lead: University of California, San Diego
National Institute on Aging (NIA)
Source: ClinicalTrials.gov ID: NCT02317523